Research Article
BibTex RIS Cite
Year 2022, Volume: 39 Issue: 2, 359 - 364, 18.03.2022

Abstract

References

  • 1. Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020; 579(7798):265-269.
  • 2. Lupia T, Scabini S, Mornese Pinna S, Di Perri G, De Rosa FG, Corcione S. 2019 novel coronavirus (2019-nCoV) outbreak: A new challenge. J Glob Antimicrob Resist. 2020; 21:22-27.

Investigation of the clinical course of Covid-19 patients according to blood groups

Year 2022, Volume: 39 Issue: 2, 359 - 364, 18.03.2022

Abstract

Objective: The aim of this study is to evaluate the effect of blood groups (BGs) on Covid-19 contraction and prognosis and to reveal the coefficients.
Methods: Patients who referred to Covid-19 outpatient clinics and had an established diagnosis of Covid-19 were included in the study. Their BGs, previous diagnoses and blood examination findings were retrospectively analyzed. Duration of hospitalization, clinical course and survival were recorded.
Results: The mean age of 365 subjects, 210 female and 155 male, was 45.5 years. Subjects with BG A developed Covid-19 at significantly higher rates (p = 0.001), while BG O was found associated with lower rates (p = 0.005). Lymphocyte count was found lower (p = 0.035) and rate of lung parenchymal involvement was higher (p = 0.003) in patients with Rh antigen. It was found that a higher percentage of patients with B BG required treatment in the intensive care unit (ICU) compared to other ABO BGs (p = 0.015).
Conclusion: These results suggest a higher risk of Covid-19 contraction in the population with BG A and lower risk for BG O population while indicating poorer prognosis for patients with BG B.

References

  • 1. Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020; 579(7798):265-269.
  • 2. Lupia T, Scabini S, Mornese Pinna S, Di Perri G, De Rosa FG, Corcione S. 2019 novel coronavirus (2019-nCoV) outbreak: A new challenge. J Glob Antimicrob Resist. 2020; 21:22-27.
There are 2 citations in total.

Details

Primary Language English
Subjects Health Care Administration
Journal Section Clinical Research
Authors

Alper Ömeroğlu This is me 0000-0002-7126-5538

Suleyman Ersoy 0000-0003-0001-9329

Emin Pala 0000-0001-9189-4342

Velittin Selçuk Engin 0000-0002-6338-4748

Early Pub Date March 18, 2022
Publication Date March 18, 2022
Submission Date July 30, 2021
Acceptance Date October 18, 2021
Published in Issue Year 2022 Volume: 39 Issue: 2

Cite

APA Ömeroğlu, A., Ersoy, S., Pala, E., Engin, V. S. (2022). Investigation of the clinical course of Covid-19 patients according to blood groups. Journal of Experimental and Clinical Medicine, 39(2), 359-364.
AMA Ömeroğlu A, Ersoy S, Pala E, Engin VS. Investigation of the clinical course of Covid-19 patients according to blood groups. J. Exp. Clin. Med. March 2022;39(2):359-364.
Chicago Ömeroğlu, Alper, Suleyman Ersoy, Emin Pala, and Velittin Selçuk Engin. “Investigation of the Clinical Course of Covid-19 Patients According to Blood Groups”. Journal of Experimental and Clinical Medicine 39, no. 2 (March 2022): 359-64.
EndNote Ömeroğlu A, Ersoy S, Pala E, Engin VS (March 1, 2022) Investigation of the clinical course of Covid-19 patients according to blood groups. Journal of Experimental and Clinical Medicine 39 2 359–364.
IEEE A. Ömeroğlu, S. Ersoy, E. Pala, and V. S. Engin, “Investigation of the clinical course of Covid-19 patients according to blood groups”, J. Exp. Clin. Med., vol. 39, no. 2, pp. 359–364, 2022.
ISNAD Ömeroğlu, Alper et al. “Investigation of the Clinical Course of Covid-19 Patients According to Blood Groups”. Journal of Experimental and Clinical Medicine 39/2 (March 2022), 359-364.
JAMA Ömeroğlu A, Ersoy S, Pala E, Engin VS. Investigation of the clinical course of Covid-19 patients according to blood groups. J. Exp. Clin. Med. 2022;39:359–364.
MLA Ömeroğlu, Alper et al. “Investigation of the Clinical Course of Covid-19 Patients According to Blood Groups”. Journal of Experimental and Clinical Medicine, vol. 39, no. 2, 2022, pp. 359-64.
Vancouver Ömeroğlu A, Ersoy S, Pala E, Engin VS. Investigation of the clinical course of Covid-19 patients according to blood groups. J. Exp. Clin. Med. 2022;39(2):359-64.